Cite
HARVARD Citation
Daftarian, N. et al. (2021). Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model. Experimental eye research. p. . [Online].